I'm curious as to what holders are thinking now. Ramping aside...

I'm curious as to what holders are thinking now. Ramping aside (everyone has an agenda), are people willing to hold out for the quarterly to see where we actually are or is this the final straw?

The status of HCT is so confusing. All these performance options that are totally unrealistic given what happened yesterday. The marketing and PR engagement and yet announcements still getting put out that are utterly amateurish. Sales failure. So many trials and relationships with distribution that just seem to evaporate.

And yet... still an amazing product line with so much potential.

As we all know, potential isn't the bottom line but where from here?